##  [ASCO 2023](/healthcare-professionals/medical-congresses-and-events/asco-annual-meeting/asco-2023 "ASCO 2023") 

 At ASCO this year, we will share new data from our robust portfolio and pipeline of advanced therapeutic platforms in cancer and blood disorders, showcasing the impact of our bold science in research.

 

##  Media releases 

 [Jun 02, 2023

- Press release

 

###  Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups

 ](/news/media-releases/novartis-kisqali-significantly-reduced-risk-recurrence-25-across-broad-population-patients-early-breast-cancer-clinically-meaningful-benefit-was-consistent-across-subgroups) [Apr 26, 2023

- Press release

 

###  Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO

 ](/news/media-releases/novartis-present-new-data-across-oncology-portfolio-including-kisqali-phase-iii-natalee-trial-early-breast-cancer-asco) 





 

 [View more](/news/news-archive?type=media_release "View more") 

 





 ![3D Illustration of molecules](/sites/novartis_com/files/styles/cta_image/public/2023-06/asco-home-desktop-banner.jpg.webp?itok=1YiiE4Ru "3D Illustration of molecules") 

 

##  ASCO for HCPs 

Novartis continues to pursue scientific breakthroughs with the ambition to transform lives and renew patients’ hopes for the future.



 

 [Learn more](https://www.asco.org/ "Learn more") 



 

 



 





 ![Scientists working in the lab at night](/sites/novartis_com/files/styles/cta_image/public/2023-05/scientists-lab-night-media-2x.jpg.webp?itok=pc5ZiabE "Scientists working in the lab at night") 

 

##  Investor Event 

June 04, 2023 | Chicago, USA

[Watch the webcast](https://edge.media-server.com/mmc/p/uzcyixj2)  
[Download the presentation (PDF 1.2 MB)](/sites/novartis_com/files/2023-06-novartis-asco-presentation.pdf "2023-06-novartis-asco-presentation.pdf")



 

 [Learn more](/investors/event-calendar "Learn more") 



 

 



 





    ![Scientists working in a laboratory with protective gear](/sites/novartis_com/files/styles/cosmos_banner_half_image_large/public/2026-02/scientist-working-in-lab-manipulating-frozen-elements-cosmos.jpg.webp?itok=a76rdTPM "Scientists working in a laboratory with protective gear") 

 

 

 

##  Progress and optimism in oncology today 

Vas Narasimhan, CEO of Novartis

 [Read Vas article on LinkedIn](https://www.linkedin.com/pulse/progress-optimism-oncology-today-vas-narasimhan?utm_source=share&utm_medium=member_ios&utm_campaign=share_via "Read Vas article on LinkedIn") 

 

 

 



 

 

 

 



##  Related topics 

 [ 

 

###  Cancer 

At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

 

 

 ](/about/therapeutic-areas/oncology/solid-tumors) [ 

 

###  Therapeutic areas 

At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs.

 

 

 ](/about/therapeutic-areas)